- Home
- PRAX vs RES Comparison
PRAX vs RES Comparison
Compare PRAX & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- RES
- Stock Information
- Founded
- PRAX 2015
- RES 1984
- Country
- PRAX United States
- RES United States
- Employees
- PRAX N/A
- RES N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- RES Oilfield Services/Equipment
- Sector
- PRAX Health Care
- RES Energy
- Exchange
- PRAX Nasdaq
- RES Nasdaq
- Market Cap
- PRAX 950.8M
- RES 1.0B
- IPO Year
- PRAX 2020
- RES N/A
- Fundamental
- Price
- PRAX $46.85
- RES $4.73
- Analyst Decision
- PRAX Strong Buy
- RES Hold
- Analyst Count
- PRAX 9
- RES 4
- Target Price
- PRAX $94.44
- RES $4.69
- AVG Volume (30 Days)
- PRAX 388.4K
- RES 1.4M
- Earning Date
- PRAX 08-04-2025
- RES 10-23-2025
- Dividend Yield
- PRAX N/A
- RES 3.40%
- EPS Growth
- PRAX N/A
- RES N/A
- EPS
- PRAX N/A
- RES 0.25
- Revenue
- PRAX $7,765,000.00
- RES $1,426,699,000.00
- Revenue This Year
- PRAX N/A
- RES $11.80
- Revenue Next Year
- PRAX $25.00
- RES $6.13
- P/E Ratio
- PRAX N/A
- RES $18.81
- Revenue Growth
- PRAX 338.45
- RES N/A
- 52 Week Low
- PRAX $26.70
- RES $4.10
- 52 Week High
- PRAX $91.83
- RES $7.22
- Technical
- Relative Strength Index (RSI)
- PRAX 47.63
- RES 52.54
- Support Level
- PRAX $44.13
- RES $4.57
- Resistance Level
- PRAX $47.06
- RES $4.82
- Average True Range (ATR)
- PRAX 2.18
- RES 0.16
- MACD
- PRAX 0.05
- RES 0.03
- Stochastic Oscillator
- PRAX 54.73
- RES 79.41
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.